Fortress Biotech Inc. (FBIOP)
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (17%) **Content type:** Clinical